Submitted by Anonymous (not verified) on 27 January 2026 - 16:00
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 17, Status: Authorised